| CANCER, AIDS AND HOSPICE CARE CD |
| Permanent storage and easy retrieval of Journal articles and formulations. |
| Only $95 per CD. |
| (Multiple Theme or Library CD orders priced at: 2 to 5 = $85; 6 to 9 = $75; 10 or more = $65 each.) |
 |
- Print Journal articles in color from the pdf file for your marketing needs.
- Eliminate long searches through past issues for articles and formulations.
|
| This CD contains the following articles listed by volume, issue and page number: |
| CANCER AND AIDS RELATED ARTICLES |
| Title | Volume/Issue | Page |
| Mechlorethamine Hydrochloride 0.02% Topical |
Vol. 13 No. 5 |
434 |
| Myristyl Nicotinate 5% Topical Gel |
Vol. 13 No. 5 |
435 |
| Aprepitant 20-mg/mL Oral Liquid |
Vol. 13 No. 2 |
153 |
| Doxorubicin Hydrochloride 1-mg/mL in Sodium Chloride Solution Intravesical Instillation |
Vol. 13 No. 2 |
155 |
| Ionic Hydration Solution for Anti-Cancer Therapy |
Vol. 13 No. 2 |
156 |
| Compounding for Cancer in Companion Animals |
Vol. 13 No. 1 |
42 |
| Compatibility and Stability of Palonosetron Hydrochloride with Lactated Ringer's, Hetastarch in Lactated Electrolyte, and Mannitol Injections During Simulated Y-Site Administration |
Vol. 12 No. 5 |
460 |
| Compounding Challenges for Immunocompromised Patients |
Vol. 12 No. 6 |
482 |
| Tretinoin and Dexpanthenol Gel |
Vol. 12 No. 4 |
361 |
| Physical and Chemical Stability of Palonosetron Hydrochloride with Glycopyrrolate and Neostigmine During Simulated Y-Site Administration |
Vol. 12 No. 4 |
368 |
| Cancer-Related Terminology: Glossaries for Compounding Pharmacists and Their Clients |
Vol. 12 No. 1 |
16 |
| Hospice and Compounding Pharmacy: Once Inseperable |
Vol. 12 No. 1 |
28 |
| Calculations: Compounding for Cancer Patients |
Vol. 12 No. 1 |
62 |
| Temozolomide 10-mg/mL Oral Liquid |
Vol. 11 No. 4 |
336 |
| Levorphanol for Excruciating Pain from Oral Cancer: A Case Report |
Vol. 11 No. 3 |
212 |
| Busulfan 2-mg/mL Oral Liquid |
Vol. 11 No. 2 |
155 |
| Ondansetron Hydrochloride 0.8mg/mL Oral Liquid |
Vol. 11 No. 2 |
158 |
| Phenoxybenzamine Hydrochloride 2-mg/mL Oral Liquid |
Vol. 11 No. 2 |
160 |
| Principles of Pediatric Palliative Care and Pain Control |
Vol. 11 No. 1 |
10 |
| Physical and Chemical Stability of Palonosetron with Metoclopramide and Promethazine During Simulated Y-Site Administration |
Vol. 11 No. 1 |
82 |
| Cyclophosphamide 2-mg/mL Oral Liquid |
Vol. 10 No. 6 |
454 |
| Dermatological Effects from Years in the Sun: Compounding Opportunities |
Vol. 10 No. 5 |
336 |
| Hydroxyurea 100 mg/mL |
Vol. 10 No. 5 |
384 |
| Indinavir 10-mg/mL Oral Liquid |
Vol. 10 No. 5 |
385 |
| Temozolomide Stability in Extemporaneously Compounded Oral Suspensions |
Vol. 10 No. 5 |
396 |
| Rifabutin 20-mg/mL Oral Liquid |
Vol. 10 No. 4 |
305 |
| Granisetron 0.05-mg/mL Oral Suspension |
Vol. 10 No. 3 |
222 |
| Mesna 20-mg/mL Syrup |
Vol. 10 No. 3 |
224 |
| Physical and Chemical Stability of Palonosetron Hydrochloride with Dacarbazine and with Methylprednisolone Sodium Succinate During Simulated Y-Site Administration |
Vol. 10 No. 3 |
234 |
| Chlorambucil 2-mg/mL Oral Liquid |
Vol. 10 No. 1 |
59 |
| Efavirenz 20-mg/mL Oral Liquid, Anhydrous |
Vol. 10 No. 1 |
62 |
| Mercaptopurine 50-mg/mL Oral Liquid |
Vol. 10 No. 1 |
64 |
| Thioguanine 40-mg/mL Oral Liquid |
Vol. 10 No. 1 |
68 |
| Dolasetron 10-mg/mL Oral Liquid |
Vol. 9 No. 6 |
475 |
| Brompton's Mixture |
Vol. 9 No. 4 |
312 |
| Physical and Chemical Stability of Palonosetron Hydrochloride with Fluorouracil and with Gemcitabine Hydrochloride during Simulated Y-site Administration |
Vol. 9 No. 4 |
320 |
| Compounding Antiangiogenic Cancer Therapy for Animals |
Vol. 9 No. 3 |
195 |
| Piroxicam 2-mg/mL Oral Liquid, Veterinary |
Vol. 9 No. 3 |
234 |
| Physical and Chemical Stability of Palonosetron Hydrochloride with Lorazepam and Midazolam Hydrochloride during Simulated Y-Site Administration |
Vol. 9 No. 3 |
235 |
| Physical and Chemical Stability of Palonosetron Hydrochloride with Topotecan Hydrochloride and Irinotecan Hydrochloride during Simulated Y-Site Administration |
Vol. 9 No. 3 |
238 |
| Book and Literature Reviews |
Vol. 8 No. 5 |
324 |
| Acyclovir 5% and Chlorhexidine Diacetate 0.2% Topical Gel |
Vol. 8 No. 5 |
383 |
| Book and Literature Reviews |
Vol. 8 No. 4 |
244 |
| Diphenhydramine HCl 0.1%, Lidocaine HCl 1%, Misoprostol 0.0024% and Triamcinolone Acetonide 0.12% Oral Rinse |
Vol. 8 No. 4 |
296 |
| Glycopyrrolate 0.5-mg/mL Oral Liquid |
Vol. 8 No. 3 |
218 |
| Stomatitis Mouthwash |
Vol. 8 No. 2 |
140 |
| Tacrolimus 0.5-mg/mL Oral Liquid |
Vol. 8 No. 2 |
141 |
| Stability of Oral Liquid Dosage Forms of Glycopyrrolate Prepared with the Use of Powder |
Vol. 7 No. 5 |
386 |
| ABHR in PLO (Lorazepam, Diphenhydramine HCl, Haloperidol, Metoclopramide HCl) |
Vol. 7 No. 3 |
183 |
| Hormonal Link to Breast Cancer: The Estrogen Matrix, The |
Vol. 6 No. 4 |
250 |
| Sterilization of Talc for Use in Pleurodesis |
Vol. 6 No. 2 |
140 |
| Antineoplastic Agents |
Vol. 5 No. 4 |
268 |
| New High-Performance Liquid Chromatographic Method for Fludarabine and Fludarabine Phosphate Compounded in Liposomes, A |
Vol. 5 No. 4 |
320 |
| Mitomycin 0.02% Ophthalmic Solution |
Vol. 5 No. 3 |
209 |
| Promethazine HCl 50-mg/mL in PLO Gel |
Vol. 5 No. 1 |
51 |
| Human Immunodeficiency Virus and the Acquired Immune Deficiency Syndrome |
Vol. 4 No. 5 |
334 |
| Hospice and the Role of the Compounding Pharmacist |
Vol. 4 No. 4 |
246 |
| Nausea and Vomiting in Hospice Patients |
Vol. 4 No. 4 |
250 |
| Ketamine for Pain in Hospice Patients |
Vol. 4 No. 4 |
253 |
| Custom-Making Medications for the Hospice Patient |
Vol. 4 No. 4 |
255 |
| Surviving Cancer - How the Compounding Pharmacist Can Help |
Vol. 4 No. 4 |
257 |
| Providing Positive Outcomes through Compounding for Animal Cancer Patients |
Vol. 4 No. 4 |
264 |
| Dacarbazine 8-mg/mL, Doxorubicin HCl 0.8-mg/mL and Ondansetron 0.64-mg/mL injection |
Vol. 4 No. 4 |
296 |
| Dexamethasone 1.2%, Lorazepam 0.1%, Haloperidol 0.1%, Diphenhydramine HCl 2.4% and Metoclopramide HCl 2.4% in PLO |
Vol. 4 No. 4 |
297 |
| Doxorubicin HCl 0.4-mg/mL, Ondansetron HCl 0.48-mg/mL and Vincristine Sulfate 14-mcg/mL Injection |
Vol. 4 No. 4 |
298 |
| Misoprostol 0.0024% Mouth Rinse for Oral Ulcerations |
Vol. 4 No. 4 |
302 |
| Ondansetron HCl 8-mg/mL in PLO |
Vol. 4 No. 4 |
305 |
| Stability of 5-Fluorouracil in an Extemporaneously Compounded Ophthalmic Solution |
Vol. 4 No. 4 |
320 |
| Tamoxifen Citrate - A Potential Therapy for the Treatment of Keloids |
Vol. 3 No. 5 |
380 |
| Tamoxifen Citrate Cream 0.1% |
Vol. 3 No. 5 |
381 |
| Compatibility of Docetaxel with Selected Drugs during Simulated Y-Site Administration |
Vol. 3 No. 3 |
241 |
| Oral Ulceration Mouthwash |
Vol. 3 No. 1 |
10 |
| Five-Day Stability of Vinorelbine in 5% Dextrose Injection and in 0.9% Sodium Chloride Injection at Room Temperature |
Vol. 3 No. 1 |
67 |
| Minimizing the Risk of Teratogenic Substance Exposure for Pregnant Compounding Pharmacists |
Vol. 2 No. 6 |
414 |
| Compatibility of Paclitaxel Injection Diluent with Two Reduced-Phthalate Administration Sets for the Acclaim Pump |
Vol. 2 No. 5 |
382 |
| Fluorouracil 5% Topical Stick |
Vol. 2 No. 4 |
300 |
| Paclitaxel Compatibility with IV Express Filter Unit |
Vol. 2 No. 3 |
243 |
| Estrogen and Breast Cancer: Is There a Link? |
Vol. 2 No. 1 |
21 |
| Ondansetron Suppositories: Extemporaneous Preparation, Drug Release, Stability and Flux through Rabbit Rectal Membrane |
Vol. 2 No. 1 |
83 |
| Stability of Mechlorethamine Hydrochloride 0.01% Ointment in Aquaphor® Base |
Vol. 2 No. 1 |
89 |
| Compounding Pharmacists Play a Vital Role in AIDS Treatment |
Vol. 1 No. 6 |
386 |
| Doxorubicin HCl-Vincristine Sulfate Injection |
Vol. 1 No. 5 |
324 |
| Granisetron HCl-Dexamethasone Sodium Phosphate Injection |
Vol. 1 No. 5 |
326 |
| Metoclopramide-Lorazepam-Mannitol-Prochlorperazine Antiemetic Injection |
Vol. 1 No. 5 |
328 |
| Ondansetron HCl-Dexamethasone Sodium Phosphate Injection |
Vol. 1 No. 5 |
332 |
| Ondansetron HCl-Doxorubicin HCl-Dacarbazine Injection |
Vol. 1 No. 5 |
333 |
| Ondansetron HCl-Doxorubicin Sulfate-Vincristine Sulfate Injection (2 concentrations) |
Vol. 1 No. 5 |
334 |
| Stability of Mitomycin Aqueous Solution When Stored in Tuberculin Syringes |
Vol. 1 No. 4 |
282 |
| Antiemetic Injection for Cancer Chemotherapy |
Vol. 1 No. 3 |
175 |
| Rectal and Stomal Administration of Analgesic Suppositories |
Vol. 1 No. 1 |
12 |
| Aromatherapy and the Hospice Patient |
Vol. 1 No. 1 |
18 |
| ABH Hard Troche |
Vol. 1 No. 1 |
26 |
| ABH Soft Troche |
Vol. 1 No. 1 |
27 |
| ABH Sugar Troche |
Vol. 1 No. 1 |
27 |
| Antiemetic Suppositories of the Gralla Type |
Vol. 1 No. 1 |
28 |
| Metoclophen Nausea Suppositories |
Vol. 1 No. 1 |
31 |
| Metoclophen-Modified Nausea Suppositories |
Vol. 1 No. 1 |
31 |
| Ondansetron HCl Suppositories |
Vol. 1 No. 1 |
34 |
| Scopolamine Hydrobromide 0.4-mg/0.1-mL Nasal Solution |
Vol. 1 No. 1 |
37 |
| Scopolamine Hydrobromide 0.25-mg/0.1-mL Topical Gel |
Vol. 1 No. 1 |
38 |
| Compounding an Extended Stability Admixture of Paclitaxel for Long-Term Infusion |
Vol. 1 No. 1 |
49 |
| HOSPICE/PALLIATIVE CARE RELATED ARTICLES |
| Title | Volume/Issue | Page |
| Compounding for Cancer in Companion Animals |
Vol. 13 No. 1 |
42 |
| Topical Treatment of Neuropathic Pain |
Vol. 12 No. 3 |
182 |
| Hospice and Compounding Pharmacy: Once Inseperable |
Vol. 12 No. 1 |
28 |
| Principles of Pediatric Palliative Care and Pain Control |
Vol. 11 No. 1 |
10 |
| Hospice Symptom Relief Kit: An Update |
Vol. 10 No. 4 |
288 |
| Aseptic Compounding in New Zealand and the Use of Still Air Boxes |
Vol. 10 No. 4 |
293 |
| Initial Selection of Antiemetics in End-of-Life Care: A Retrospective Analysis |
Vol. 10 No. 2 |
147 |
| Hospice from a Compounding Pharmacist's Perspective |
Vol. 10 No. 2 |
89 |
| ABHR Gel in the Treatment of Nausea and Vomiting in the Hospice Patient |
Vol. 10 No. 2 |
95 |
| The Story of Hospice |
Vol. 10 No. 2 |
100 |
| The Dying Process |
Vol. 10 No. 2 |
103 |
| Current Topical Treatments in Wound Healing - Part 1 |
Vol. 8 No. 4 |
269 |
| Scopolamine Hydrobromide 0.25-mg/0.1-mL Topical Gel |
Vol. 8 No. 3 |
185 |
| Indomethacin 50-mg Suppositories |
Vol. 7 No. 5 |
375 |
| ABHR in PLO (Lorazepam, Diphenhydramine HCl, Haloperidol, Metoclopramide HCl) |
Vol. 7 No. 3 |
183 |
| Hospice and the Role of the Compounding Pharmacist |
Vol. 4 No. 4 |
246 |
| Nausea and Vomiting in Hospice Patients |
Vol. 4 No. 4 |
250 |
| Ketamine for Pain in Hospice Patients |
Vol. 4 No. 4 |
253 |
| Custom-Making Medications for the Hospice Patient |
Vol. 4 No. 4 |
255 |
| Basics of Compounding: Compounding Suppositories: Part I - Theoretical Considerations |
Vol. 4 No. 4 |
289 |
| Dexamethasone 1.2%, Lorazepam 0.1%, Haloperidol 0.1%, Diphenhydramine HCl 2.4% and Metoclopramide HCl 2.4% in PLO |
Vol. 4 No. 4 |
297 |
| Managing Pain in the Terminally Ill |
Vol. 2 No. 2 |
111 |
| Symptom Relief Kit for Hospice Patients, The |
Vol. 2 No. 2 |
116 |
| Compounding Pharmacists Play a Vital Role in AIDS Treatment |
Vol. 1 No. 6 |
386 |
| Hospice Care and the Pharmacist |
Vol. 1 No. 1 |
11 |
| Rectal and Stomal Administration of Analgesic Suppositories |
Vol. 1 No. 1 |
12 |
| Aromatherapy and the Hospice Patient |
Vol. 1 No. 1 |
18 |
| Aromatherapy Mood Elevation No. 1 |
Vol. 1 No. 1 |
20 |
| Aromatherapy Mood Elevation No. 2 |
Vol. 1 No. 1 |
21 |
| ABH Hard Troche |
Vol. 1 No. 1 |
26 |
| ABH Soft Troche |
Vol. 1 No. 1 |
27 |
| ABH Sugar Troche |
Vol. 1 No. 1 |
27 |
| Morphine Sulfate Slow-Release Suppositories |
Vol. 1 No. 1 |
32 |
| Ondansetron HCl Suppositories |
Vol. 1 No. 1 |
34 |
| Morphine Suppositories |
Vol. 1 No. 1 |
36 |